Market Share of Serological Tests Stays Atop
Given the demand for continuous improvement in outcomes and quality of diagnostics, preference for serological tests will remain high throughout the forecast period. Their benefits of rapid and accurate diagnosis of phytopathological diseases are making them a high priority for market players.
Among various serological tests, tissue blot immuno assays (TBIA) and quartz crystal microbalance immunosensors (QCMI) will be at the forefront. While serological tests are capturing a larger proportion in the phytopathological disease diagnostics market, molecular tests and tests using electronic technology are likely to see stagnancy in their adoption.
Opportunities Prevail in Europe
Europe would lead the way in the phytopathological disease diagnostics market, procuring nearly 2/5 of overall market revenues. Being a hub of tech-enabled transformations in the healthcare vertical, upsurge in private spending in agriculture R&D activities is critical in driving market growth in developed region.
Moreover, governments in Europe have introduced standardized diagnostic protocols such as the European and Mediterranean Plant Protection Organization (EPPO) for pest control services. Represented by Spain and Italy, such factors are garnering huge attention of market players.
Stakeholders to Embrace Digitally-driven Approach
Digital maturity is linearly associated with enhanced market performance. Players in the phytopathological disease diagnostics market must move aggressively and create comprehensive strategies to integrate digitalization into their approaches. For instance, Peat, an ag-tech startup, has developed a mobile app called Plantix, to detect diseases in crops.
The app analyzes the captured image of the crop and reveals the data, which is further stored on the server to improve the algorithms for detecting plant diseases. Market players must, thus, invest in digitalization to accelerate sales growth and broaden their customer base.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
How Growth will Unfold
Around 40% of overall market value is realized by phytopathological disease diagnostic kits, and the number will surge at a healthy pace in the coming years. Under the product category, DNA-based diagnostic kits and enzyme-linked immunosorbent assay (ELISA) kits are leading the pack.
However, the intensifying need for better clinical outcomes in phytopathological disease diagnostics is enabling broader adoption of lateral flow devices. Although holding relatively lesser revenue share, market players are focusing on unlocking value-creation opportunities from lateral flow devices.
FREQUENTLY ASKED QUESTIONS ABOUT PHYTOPATHOLOGICAL DISEASE DIAGNOSTICS MARKET
Which region is expected to be at the forefront in terms of revenue in the global phytopathological disease diagnostics market?
Europe is dominating the phytopathological disease diagnostics market in terms of revenue, owing to the rapid adoption of advanced diagnostic technology. East Asia is expected to offer lucrative opportunities for the global phytopathological disease diagnostics market in the coming years.
Which product segment would be the most attractive for investments?
Kits has emerged as the most attractive segment by product, owing to diverse product availability and significant usage.
Which test segment would be the most prominent during the forecast period?
The serological tests segment is expected to be most prominent in the phytopathological disease diagnostics market, owing to their properties such as ready-to-use and rapid and instant test results.
Which sample segment would be the most prominent in terms of revenue?
By sample, plants dominated the phytopathological disease diagnostics market in terms of revenue, as most diseases are linked with whole plants, and hence, used as a sample in most of the diagnostic tests.
Which end user would contribute maximum revenue share during the forecast period?
Contract research organizations are expected to gain maximum share in the phytopathological disease diagnostics market, as governments in various countries are developing numerous platforms by creating more research-focused plant health surveillance.
What strategies are prominent players in the phytopathological disease diagnostics market following?
Thermo Fischer Scientific, Clear Detections B.V, Merck KGaA, Agdia, Inc., and Qualiplante are the top five players in the global phytopathological disease diagnostics market. New product development and subsequent launches are key strategies being followed by these players.
What are the impediments to the growth of the phytopathological disease diagnostics market?
Some of the prominent factors that might hamper the growth of the phytopathological disease diagnostics market are lack of skilled personnel and limited knowledge about plant health. High costs associated with diagnosis and preference for conventional methods are other factors hampering market growth.
PHYTOPATHOLOGICAL DISEASE DIAGNOSTICS MARKET TAXONOMY
The global phytopathological disease diagnostics is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
- ELISA Kits
- DNA-based Diagnostics Kits
- Protein-based Diagnostics Kits
- Lateral Flow Devices
- DNA/RNA Probes
- Accessories and Other Consumables
- Software and Cloud Databases
- Molecular Tests
- PCR-based Assays
- PCR & RT-PCR
- Multiplex PCR
- Isothermal Amplification Assays
- Microarray Assays
- LAMP Assays
- PCR-based Assays
- Serological Tests
- Tests Using Electronic Technology
- Agricultural Laboratories
- Academic and Research Institutes
- Food Processing Laboratories
- Contract Research Organizations
- North America
- Latin America
- East Asia
- South Asia
- Middle East & Asia (MEA)